These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 7133349)

  • 1. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.
    Kassell NF; Peerless SJ; Durward QJ; Beck DW; Drake CG; Adams HP
    Neurosurgery; 1982 Sep; 11(3):337-43. PubMed ID: 7133349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of ischemic deficits from vasospasm with intravascular volume expansion and induced arterial hypertension.
    Iberti TJ
    Neurosurgery; 1983 Jun; 12(6):705-6. PubMed ID: 6877556
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Therapeutic value of treatment with calcium antagonists, hypervolemic hemodilution and induced arterial hypertension].
    Hansen D; Hannemann L; Specht M; Schaffartzik W
    Anaesthesist; 1995 Apr; 44(4):219-29. PubMed ID: 7785750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Normovolaemic induced hypertension therapy for cerebral vasospasm after subarachnoid haemorrhage.
    Otsubo H; Takemae T; Inoue T; Kobayashi S; Sugita K
    Acta Neurochir (Wien); 1990; 103(1-2):18-26. PubMed ID: 2360462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage.
    Miller JA; Dacey RG; Diringer MN
    Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral vasospasm after subarachnoid hemorrhage: an update.
    Heros RC; Zervas NT; Varsos V
    Ann Neurol; 1983 Dec; 14(6):599-608. PubMed ID: 6651248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Intraventricular and intracerebral hemorrhage as complication of hemodynamic therapy for vasospasm after subarachnoid hemorrhage--analysis of 2 cases].
    Ishiguro S; Kimura A; Munemoto S; Ikeda M; Shoin K
    No Shinkei Geka; 1985 Dec; 13(12):1343-7. PubMed ID: 2418382
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of intravascular volume expansion on cerebral blood flow in patients with ruptured cerebral aneurysms.
    Yamakami I; Isobe K; Yamaura A
    Neurosurgery; 1987 Sep; 21(3):303-9. PubMed ID: 3670573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical vasospasm after subarachnoid hemorrhage: response to hypervolemic hemodilution and arterial hypertension.
    Awad IA; Carter LP; Spetzler RF; Medina M; Williams FC
    Stroke; 1987; 18(2):365-72. PubMed ID: 3564092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induced hypertension and hypervolemia for treatment of cerebral vasospasm.
    Levy ML; Giannotta SL
    Neurosurg Clin N Am; 1990 Apr; 1(2):357-65. PubMed ID: 2136148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage.
    Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P
    Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The safety of vasopressor-induced hypertension in subarachnoid hemorrhage patients with coexisting unruptured, unprotected intracranial aneurysms.
    Reynolds MR; Buckley RT; Indrakanti SS; Turkmani AH; Oh G; Crobeddu E; Fargen KM; El Ahmadieh TY; Naidech AM; Amin-Hanjani S; Lanzino G; Hoh BL; Bendok BR; Zipfel GJ
    J Neurosurg; 2015 Oct; 123(4):862-71. PubMed ID: 26207606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage.
    Muehlschlegel S; Dunser MW; Gabrielli A; Wenzel V; Layon AJ
    Neurocrit Care; 2007; 6(1):3-10. PubMed ID: 17356185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiopathological criteria of vasospasm treatment.
    Tommasino C; Picozzi P
    J Neurosurg Sci; 1998 Mar; 42(1 Suppl 1):23-6. PubMed ID: 9800598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral vasospasm.
    Weir B; MacDonald L
    Clin Neurosurg; 1993; 40():40-55. PubMed ID: 8111992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of severe cerebral vasospasm in three patients after aneurysmal subarachnoid hemorrhage: initial observations regarding the use of intraventricular sodium nitroprusside in humans.
    Thomas JE; Rosenwasser RH
    Neurosurgery; 1999 Jan; 44(1):48-57; discussion 57-8. PubMed ID: 9894963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm.
    Shimoda M; Oda S; Tsugane R; Sato O
    J Neurosurg; 1993 Mar; 78(3):423-9. PubMed ID: 8433144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serious pitfalls which can be encountered in a course of hypertension-hypervolemia therapy for vasospasm].
    Abe S; Wada T; Miyazaki Y; Kanki T; Hashimoto T; Nakamura N
    No Shinkei Geka; 1992 Apr; 20(4):357-65. PubMed ID: 1570056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current concepts of pathophysiology and management of cerebral vasospasm following aneurysmal subarachnoid hemorrhage.
    Findlay JM; Macdonald RL; Weir BK
    Cerebrovasc Brain Metab Rev; 1991; 3(4):336-61. PubMed ID: 1772740
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of the extracranial-intracranial arterial bypass in the management of refractory vasospasm: a case report.
    Rosenstein J; Batjer HH; Samson DS
    Neurosurgery; 1985 Sep; 17(3):474-9. PubMed ID: 4047359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.